相关实验视频
Updated: Jun 17, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
TIMP1通过通过PI3K/AKT信号通路通过巨细胞的表型极化促进甲状腺癌细胞的进展
Xu Lin1, Ruhua Zhao1, Yu Bin1
1Department of Morphology Laboratory, Hebei North University, Zhangjiakou 075000, China.
金属蛋白酶1 (TIMP1) 的组织抑制剂在乳头甲状腺癌 (PTC) 中被上调,并通过影响免疫细胞来促进瘤生长. 抑制TIMP1可以减少PTC恶性瘤,并改变巨细胞的两极分化.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 金属蛋白酶1 (TIMP1) 的组织抑制剂与免疫调节有关.
- 在包括甲状腺癌在内的各种恶性瘤中,TIMP1被上调.
研究的目的:
- 调查TIMP1在乳头甲状腺癌 (PTC) 中的作用.
- 检查TIMP1在PTC中对瘤相关巨细胞 (TAMs) 的调节.
主要方法:
- 在PTC中分析TIMP1表达的分析.
- 在PTC细胞中抑制TIMP1表达.
- 对巨细胞极化 (M1/M2) 的评估.
- 通过ELISA测量细胞因子水平 (IL-10,TGF-β).
主要成果:
- TIMP1在PTC上调节,并影响瘤微环境 (TME).
- 抑制TIMP1可以减少PTC细胞恶性瘤,并阻碍M2巨细胞的两极分化,同时促进M1两极分化.
- 下调的TIMP1与IL-10和TGF-β水平降低相关.
- TIMP1可能通过PI3K/AKT通路促进PTC进展,影响TAMs.
结论:
- TIMP1通过调节TAMs和炎症TME在PTC进展中发挥着重要作用.
- 针对TIMP1可能是PTC的治疗策略.
更多相关视频
10:23Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures
Published on: December 14, 2019
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Abnormal Proliferation
The JAK-STAT Signaling Pathway